If this page doesn't display properly in your email, Click here

February 2008
Volume 18, Issue 2


In the IDSA Journals

Teaser here...Read More



Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus

European health officials have reported finding oseltamivir resistance in a surprisingly high percentage of H1N1 influenza virus isolates tested so far this season....Read More



EIN: Decolonize MRSA Patients or Not?

An Emerging Infections Network (EIN) member in Saudi Arabia asked whether he   should attempt to decolonize a 53-year-old male patient with psoriasis carrying methicillin-resistant Staphylococcus aureus (MRSA).

...Read More



Multidrug-resistant Staph Reported among MSM

The Annals of Internal Medicine last month reported an outbreak of a multi-drug resistant strain of virulent Staphylococcus aureus among men who have sex with men in San Francisco and Boston....Read More



Health Alerts, Drug Approvals, Recalls, Adverse Events

...Read More



IDSA Policy & Advocacy Update: IDSA Opposes Anti-Thimerosal Legislation

IDSA continues to advocate at the state level against legislation banning the use of thimerosal in vaccines due to unfounded concerns about its link to autism. ...Read More



CDC Survey Shows Less Effective Flu Medications Still Used

A recent survey conducted by the Centers for Disease Control and Prevention (CDC) suggests that many primary care physicians (PCPs) prescribed amantadine and rimantadine last influenza season despite a warning about viral resistance.

...Read More



Third Seasonal and Pandemic Influenza Meeting: May 18-20

Teaser here...Read More



Meeting on Key Issues in TB Drug Development May 5 - 6, 2008, New Delhi, India

...Read More



Welcome, New IDSA Members!

...Read More



Calendar of Future Meetings and Events

...Read More



CMS Requires NPI on Claims Starting March 1

Teaser here...Read More

In the IDSA Journals
Europe Reports High Percentage of Oseltamivir-resistant Influenza Virus
EIN: Decolonize MRSA Patients or Not?
Multidrug-resistant Staph Reported among MSM
Health Alerts, Drug Approvals, Recalls, Adverse Events
IDSA Policy & Advocacy Update: IDSA Opposes Anti-Thimerosal Legislation
CDC Survey Shows Less Effective Flu Medications Still Used
Third Seasonal and Pandemic Influenza Meeting: May 18-20
Meeting on Key Issues in TB Drug Development
Welcome, New IDSA Members!
Calendar of Future Meetings and Events
CMS Requires NPI on Claims Starting March 1

Dates to Remember

Oct. 25-29, 2008
IDSA/ICAAC Joint Meeting
Washington, DC
Abstract submission deadline: May 19, 2008

June 3-4, 2008
Fellows' In-Training Exam

Oct. 29-Nov. 1, 2009
47th Annual Meeting of IDSA
Philadelphia, PA

 



Search Back Issues
Forward this Issue
Print-Friendly Version
Unsubscribe

Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

To ensure delivery of IDSA News please add idsanews@idsociety.org to your email address book or Safe Sender List. If you are still having
problems receiving our communications, see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA